Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen Reiterates Buy Rating on Evolent Health (EVH)
-
TD Cowen Reiterates Buy Rating on Evolent Health (EVH)
-
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024
-
Evolent Health to Participate in Upcoming Conferences
-
Evolent Health (EVH) PT Raised to $63 at Cowen
-
Evolent Health to Participate in Upcoming Investor Conferences
-
Evolent Health (EVH) PT Raised to $32 at Cowen
-
Evolent Health to Participate in Upcoming Investor Conference
-
Evolent Health (EVH) PT Raised to $19 at Cowen
-
Evolent Health (EVH) PT Lowered to $13 at Cowen
-
Evolent Health to Participate in Upcoming Investor Conferences
-
Evolent Health (EVH) Sell-Off 'Overdone' - Cowen
-
Evolent Health (EVH) PT Lowered to $18 at Cowen
-
Evolent Health (EVH) PT Lowered to $19 at Cowen Following Analyst Day
-
Evolent Health (EVH): New Partnerships Should Offset Potential Headwinds - Cowen
-
Evolent Health (EVH) PT Lowered to $33 at Cowen; Reiterates Outperform
-
Evolent Health (EVH) Prices Upsized 7.5M Share Common Stock Offering
-
Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock
-
Evolent Health, Inc. Announces Pricing of Upsized Secondary Public Offering of Class A Common Stock
-
Evolent Health, Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
-
Evolent Health, Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
-
Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report
-
Cowen Starts Evolent Health (EVH) at Outperform

